loadpatents
Patent applications and USPTO patent grants for Giardina; Giuseppe.The latest application filed is for "quinoline derivatives as nk-3 and nk-2 antagonists".
Patent | Date |
---|---|
Quinoline Derivatives as NK-3 and NK-2 Antagonists App 20070015766 - Farina; Carlo ;   et al. | 2007-01-18 |
Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists App 20060235026 - Farina; Carlo ;   et al. | 2006-10-19 |
3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists App 20060229315 - FARINA; Carlo ;   et al. | 2006-10-12 |
Quinoline Derivatives as NK-3 Antagonists App 20060223819 - Farina; Carlo ;   et al. | 2006-10-05 |
Benzosuberonylpiperdine compounds as analgesics Grant 7,115,633 - Barlocco , et al. October 3, 2 | 2006-10-03 |
Novel compounds App 20060161004 - Farina; Carlo ;   et al. | 2006-07-20 |
Novel compounds App 20050070574 - Farina, Carlo ;   et al. | 2005-03-31 |
3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists App 20040180902 - Farina, Carlo ;   et al. | 2004-09-16 |
Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists Grant 6,780,875 - Farina , et al. August 24, 2 | 2004-08-24 |
Novel compounds App 20040102633 - Farina, Carlo ;   et al. | 2004-05-27 |
Quinoline derivatives as nk-3 antagonists App 20040097518 - Farina, Carlos ;   et al. | 2004-05-20 |
Quinoline derivatives as nk-3 and nk-2 antagonists App 20040082589 - Farina, Carlo ;   et al. | 2004-04-29 |
Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists App 20040077658 - Farina, Carlo ;   et al. | 2004-04-22 |
Benzosuberonylpiperdine compounds as analgesics App 20040029917 - Barlocco, Daniela ;   et al. | 2004-02-12 |
Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists App 20030212101 - Farina, Carlo ;   et al. | 2003-11-13 |
Quinoline derivatives as NK-2 and NK-3 receptor ligands Grant 6,613,770 - Farina , et al. September 2, 2 | 2003-09-02 |
N-acyl-substituted azacyclic compounds, processes for their preparaion, and their use as pharmaceuticals Grant 5,366,981 - Vecchietti , et al. November 22, 1 | 1994-11-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.